trombosis cerebral en presencia de un inhibidor especifico contra el factor xii de la coagulación

Clicks: 5
ID: 203794
1998
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #295 of 320 articles by views in european journal of cancer prevention : the official journal of the european cancer prevention organisation (ecp)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 320 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
We report the presence of an specific inhbitor directed against Hageman factor (factor XII) in a male patient who suffered occlusive stroke and showed tomografic evidence of multiple previous brain infarcts. The presence of a lupus anticoagulant was excluded by means of the platelet neutralisation test. The reduction of the fibrinolytic activity in response to thrombosis as a result of factor XII inhibition was demonstrated by the abnormal prolongation of the euglobin lysis time as well as the absence of fibrin degradation products (negative D-dimer assay and ethanol gelation test).
Reference Key
betancur1998revistatrombosis Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Octavio Martínez Betancur;Inés López de Goenaga
Journal european journal of cancer prevention : the official journal of the european cancer prevention organisation (ecp)
Year 1998
DOI
DOI not found
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.